Irina Koffler has been working as a relationship manager and in corporate communications with LifeSci advisors since 2019. She has 13 years of sell-side experience covering specialty …

SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by developing …

Irina Koffler is currently the Managing Director at LifeSci Advisors, LLC, where Irina specializes in equity research analysis focusing on specialty pharmaceuticals. Prior to their current role, Irina …

2015年7月17日 · Mizuho Securities USA , the U.S. investment banking subsidiary of Mizuho Financial Group , has appointed Irina Koffler Managing Director and Senior Analyst leading …

2015年7月17日 · Mizuho Securities USA (MSUSA), the US investment subsidiary of Mizuho Financial Group (NYSE: MFG), has named Irina Koffler as its newest Managing Director and …

Irina Koffler contact details: Email address: i***@lifesciadvisors.com Phone number: (646) ***-**** Who is Irina Koffler? Irina Koffler is a Managing Director at LifeSci Advisors based in New …

Irina Rivkind Koffler is a senior equity research analyst covering specialty pharmaceuticals with Cantor Fitzgerald. Prior to joining Cantor in 2011, she worked for Duncan-Williams Inc., where …

JERSEY CITY, N.J., May 08, 2024 (GLOBE NEWSWIRE) -- SCYNEXIS, Inc. (NASDAQ: SCYX), a biotechnology company pioneering innovative medicines to overcome and prevent difficult-to …

Irina Rivkind Koffler is a senior equity research analyst covering specialty pharmaceuticals with Cantor Fitzgerald. Prior to joining Cantor in 2011, she worked for Duncan-Williams Inc. where …